Skip to content

Understanding Your Diagnostic Test: What It Is, Why It Is Done, and What Your Results Mean

Published: August 9, 2026Updated: August 16, 2026

This test checks for the presence of acetyl fentanyl, a synthetic opioid, in umbilical cord tissue to determine if a newborn was exposed to this substance during pregnancy.

Quick summary

{"Detects acetyl fentanyl exposure in unborn babies through cord tissue testing","Used to identify opioid exposure during pregnancy","Results help healthcare providers provide appropriate care for mother and baby","Positive results do not confirm addiction but indicate prenatal exposure","Follow-up testing and support services may be recommended"}

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
97214-1
Short code
ACET-FENT-CORD
Synonyms
Acetyl fentanyl TissCo Ql Scn
Category
chemistry
Sample
serum
Container
Cord tissue container (sterile container) or serum separator tube (SST) if collecting blood samples
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
≥ 0 years
Method
screen
CPT
80307 (Drug testing, per screen, each drug class)
SNOMED
373449006 (Fentanyl measurement)
Specimen volume
Cord tissue: Minimum 5-10 grams of cord tissue preferred; Serum: 1-2 mL minimum
Stability
Cord tissue: Refrigerated (2-8°C) for up to 7 days; Frozen (-20°C or below) for longer storage up to 30 days. Serum: Refrigerated 7 days, Frozen 30 days
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
24–72 hours
Order
routine

This is a diagnostic test that helps your healthcare provider learn more about how your body is working. It may be done on its own or as part of a routine checkup, and it gives your care team valuable information to guide decisions about your health and any treatment you may need.

The acetyl fentanyl test is a screening test performed on umbilical cord tissue after birth. It detects whether the baby was exposed to acetyl fentanyl, a powerful synthetic opioid, while in the womb. Cord tissue is used because it can reveal drug exposure that occurred during the later stages of pregnancy, as substances can cross the placenta and accumulate in fetal tissues.

Your doctor may order this test to look for signs of illness, confirm or rule out a suspected condition, monitor a health problem you already know about, or check how well a current treatment is working. The results help your care team choose the safest and most effective plan for you.

This test is typically performed as part of routine newborn screening or when healthcare providers suspect possible drug exposure during pregnancy. It helps identify infants who may need additional monitoring and care due to prenatal opioid exposure. Early detection allows healthcare teams to provide appropriate support and resources to both the mother and baby.

What happens during the test depends on the type ordered, but most tests are quick and cause little discomfort. A member of your care team will explain each step before it begins, and you can ask questions at any time. You may be asked to sit or lie still while a sample is collected or a measurement is taken.

After the baby is born, a small piece of umbilical cord tissue is collected as part of the delivery process. The tissue is then sent to a laboratory where it is analyzed for the presence of acetyl fentanyl and its metabolites. The sample is typically collected before the cord is discarded, so no additional procedures or pain is involved for the baby.

Once the test is complete, your results will be reviewed by your healthcare provider, who will explain what they mean in plain language. Results outside the usual range do not always mean something is seriously wrong, so follow up with your provider to discuss your numbers and any next steps.

Results are reported as either "Detected" (positive) or "Not Detected" (negative). A positive result indicates that acetyl fentanyl was found in the cord tissue, suggesting the baby was exposed to this substance during pregnancy. A negative result means no detectable levels of acetyl fentanyl were found in the cord tissue at the time of delivery.

Reference range

Not Detected / Negative - Cutoff concentration: 0.5 ng/g or as established by laboratoryN/A

Specimen: serum

No specific patient preparation required. For cord tissue collection, collection should occur immediately after delivery. Ensure proper identification and chain of custody documentation.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

Identifying prenatal exposure to acetyl fentanyl is important for neonatal care. Babies born to mothers who used acetyl fentanyl during pregnancy may experience neonatal abstinence syndrome (NAS) or other withdrawal symptoms shortly after birth. Early identification allows healthcare providers to monitor the baby closely and provide appropriate treatment if needed. This testing also helps connect families with support services, substance abuse counseling, and follow-up care resources.

Acetyl fentanyl is an extremely potent synthetic opioid that is often mixed with other drugs and may be unknowingly consumed. Its presence in cord tissue indicates exposure but does not necessarily indicate maternal opioid use disorder. The test is a screening tool designed to ensure appropriate care for both mother and infant.

Frequently asked questions

Does a positive result mean my baby will have problems?
Not necessarily. A positive result indicates exposure, but the severity of effects varies greatly. Some babies may show no symptoms, while others may require monitoring or treatment for withdrawal. Healthcare providers will assess your baby individually and provide appropriate care.
Will this test be shared with law enforcement?
This test is a medical screening tool designed for clinical care, not legal purposes. Medical professionals are bound by confidentiality laws and focus on providing appropriate healthcare and support services. The goal is to ensure the health and safety of both mother and baby.
What happens if the test is positive?
If acetyl fentanyl is detected, your healthcare team will discuss the results with you and develop a care plan for your baby. This may include monitoring for withdrawal symptoms, providing appropriate treatment if needed, and offering resources for follow-up care and support services.
Can I refuse this test?
You may discuss testing options with your healthcare provider. In some settings, testing may be part of standard newborn screening protocols. It's important to discuss any concerns with your healthcare team to understand the benefits and implications of testing.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy